Ureteral Stones
7
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
29%
2 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Ureteroscope Caliber and Surgeon Stress
Pain Control During ESWL Using Non-Opioid Analgesics
Evaluating Postoperative Pain After Ureterorenoscopy.
Antibiotic Prophylaxis Before Shock Wave Lithotripsy
ESWL vs URS in Management of Upper Third Ureteric Calculi
The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients
Is Prophylactic Antibiotics Necessary In Otherwise Healthy Adult Patients Undergoing Ureteroscopic Procedures for Ureteral Stones?